NDC product
POTASSIUM CITRATE
NDC 72865-191 · XLCare Pharmaceuticals, Inc.
Key facts
| Product NDC | 72865-191 |
|---|---|
| Proprietary name | POTASSIUM CITRATE |
| Nonproprietary name | Potassium Citrate |
| Substances | POTASSIUM CITRATE |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | XLCare Pharmaceuticals, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA214420 |
| Pharmacologic classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| Marketing start | Feb 25, 2021 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: